University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

High use of SABAs is associated with higher exacerbation rate in Dutch patients with asthma

dc.contributor.authorBaron, A.J
dc.contributor.authorFlokstra-de Blok , B.M.J
dc.contributor.authorKerstjens, Huib AM
dc.contributor.authorKoopmans-Klein , G
dc.contributor.authorPrice, David
dc.contributor.authorSellink , A.A
dc.contributor.authorTsiligianni, I
dc.contributor.authorKocks, J.W.H
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2021-07-13T10:41:00Z
dc.date.available2021-07-13T10:41:00Z
dc.date.issued2021-07-12
dc.descriptionFunding This study is funded by General Practitioners Research Institute and AstraZeneca Netherlands. The REALISE survey was funded by Mundipharma International Limited (Cambridge, UK). Acknowledgements We would like to thank the core study team, Thys van der Molen, Monica Fletcher, and David Price, the initial researchers of the REALISE study, for their advice on this study. We would like to thank Mundipharma Pharmaceuticals the Netherlands, for providing the data for this study.en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent2141972
dc.identifier195641798
dc.identifierfecf89e5-9fc9-44f9-aa3e-bbceeb8dd662
dc.identifier85111051634
dc.identifier.citationBaron, A J, Flokstra-de Blok , B M J, Kerstjens, H AM, Koopmans-Klein , G, Price, D, Sellink , A A, Tsiligianni, I & Kocks, J W H 2021, 'High use of SABAs is associated with higher exacerbation rate in Dutch patients with asthma', Journal of Asthma and Allergy, vol. 2021, no. 14, pp. 851—861. https://doi.org/10.2147/JAA.S292943en
dc.identifier.doi10.2147/JAA.S292943
dc.identifier.iss14en
dc.identifier.issn1178-6965
dc.identifier.urihttps://hdl.handle.net/2164/16812
dc.language.isoeng
dc.relation.ispartofJournal of Asthma and Allergyen
dc.subjectasthmaen
dc.subjectshort acting beta2-agonisten
dc.subjectSABAen
dc.subjectprimary health careen
dc.subjectadverse effectsen
dc.subjectguidelinesen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleHigh use of SABAs is associated with higher exacerbation rate in Dutch patients with asthmaen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Baron_etal_JAA_High_Use_Of_VoR.pdf
Size:
2.04 MB
Format:
Adobe Portable Document Format

Collections